XRAY vs HSIC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 19, 2026

XRAY

60.2
AI Score
VS
XRAY Wins

HSIC

46.2
AI Score

Investment Advisor Scores

XRAY

60score
Recommendation
HOLD

HSIC

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric XRAY HSIC Winner
Forward P/E 7.728 17.3913 XRAY
PEG Ratio 0.7727 2.0467 XRAY
Revenue Growth -4.1% 6.7% HSIC
Earnings Growth 15.2% 17.1% HSIC
Tradestie Score 60.2/100 46.2/100 XRAY
Profit Margin -15.0% 3.0% HSIC
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

XRAY 1M: -14.2% · 3M: +10.0% HSIC 1M: +4.7% · 3M: +20.4%

Current Technical Phase

XRAY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 36.2 · Price: $10.92

HSIC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.4% over 20 days), RSI 56

RSI (14): 55.7 · Price: $88.50

Fundamentals Snapshot

Metric XRAY HSIC
Market Cap
Forward P/E 7.2 14.8
Trailing P/E 26.0
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.3%
Operating Margin 0.1% 0.1%
EPS -2.71 3.40
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, XRAY is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.